Keck School Faculty

Gary Robert Lerner, MD
Gary Robert Lerner, MD
Associate Professor of Clinical Pediatrics (Part-Time)
Pediatrics
CHL Mail Stop 40 Off Campus Los Angeles

Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease Pediatr Nephrol. 2017 Jul; 32(7):1221-1232. . View in PubMed

Darbepoetin alfa for the treatment of anemia in pediatric patients with chronic kidney disease Pediatr Nephrol. 2006 Aug; 21(8):1144-52. . View in PubMed

Experience with autogenous arteriovenous access for hemodialysis in children and adolescents Ann Vasc Surg. 2005 Sep; 19(5):609-12. . View in PubMed

Iron therapy in the pediatric hemodialysis population Pediatr Nephrol. 2004 Jun; 19(6):655-61. . View in PubMed

Safety and pharmacokinetics of ascending single doses of sirolimus (Rapamune, rapamycin) in pediatric patients with stable chronic renal failure undergoing dialysis Pediatr Transplant. 2004 Apr; 8(2):151-60. . View in PubMed

Pharmacokinetics of darbepoetin alfa in pediatric patients with chronic kidney disease Pediatr Nephrol. 2002 Nov; 17(11):933-7. . View in PubMed

Chronic dialysis in children and adolescentsThe 1996 annual report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol. 1999 Jun; 13(5):404-17. . View in PubMed

Urinary tract infections in children Pediatr Ann. 1994 Sep; 23(9):463466-73. . View in PubMed

Renal cortical and renal medullary necrosis in the first 3 months of life Pediatr Nephrol. 1992 Nov; 6(6):516-8. . View in PubMed

Powered by SC CTSI
Go to Top